{"title":"在提高运动成绩、增强肌肉力量和肥大方面，血流限制疗法和运动并不比单独运动更好：系统综述和荟萃分析。","authors":"Dimple Khurana, Neha Dutta, Shikha Malik, Shalini Sharma, M Minhaj, Raj Kumar Sharma, Saurabh Sharma","doi":"10.1080/08990220.2023.2181328","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The benefits of Blood Flow Restriction Therapy (BFRT) have gained attention in recent times.</p><p><strong>Objective: </strong>This review aimed to evaluate the immediate (up to 24 hours), intermediate (up to 6 weeks), and long term (6-10 weeks) effects of BFRT plus exercises (EX) compared to EX only on athletic performance (sprint and jump performance), muscle strength, and hypertrophy in athletes and physically active population.</p><p><strong>Methods: </strong>A literature search was conducted to select randomized controlled trials across four electronic databases from inception till April 2021. The search yielded twenty-seven studies in total.</p><p><strong>Results: </strong>Based on eligibility criteria, twenty-one studies were analyzed. No differences were found between both groups for immediate (standardized mean difference [SMD] -0.02, 95% confidence interval [CI] -0.31, 0.27) and long-term effects (SMD -0.30, 95%CI -0.90, 0.30) on sprint performance. For jump performance, no significant effect was observed immediately (SMD -0.02 (95% CI -1.06, 1.02) and long term (SMD -0.40 (95% CI -1.46, 0.67). Similarly, muscle torque at intermediate (SMD 0.90 (95% CI -1.01, 2.81) and long term (SMD -0.54 (95% CI -1.19, 0.12), muscle strength at intermediate (SMD 1.12 (95% CI 0.20, 2.04), and long term (SMD -0.07 (95% CI -0.56, 0.42) also showed non-significant effects. Muscle hypertrophy at intermediate (SMD 0.16 (95% CI -0.31, 0.63) and long term (SMD -0.20 (95% CI -0.90, 0.50) were not statistically significant.</p><p><strong>Conclusions: </strong>There was no significant difference observed in BFRT plus EX group compared to the EX-group on athletic performance, muscle strength, and muscle hypertrophy.</p>","PeriodicalId":49498,"journal":{"name":"Somatosensory and Motor Research","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Blood flow restriction therapy with exercise are no better than exercise alone in improving athletic performance, muscle strength, and hypertrophy: a systematic review and meta-analysis.\",\"authors\":\"Dimple Khurana, Neha Dutta, Shikha Malik, Shalini Sharma, M Minhaj, Raj Kumar Sharma, Saurabh Sharma\",\"doi\":\"10.1080/08990220.2023.2181328\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The benefits of Blood Flow Restriction Therapy (BFRT) have gained attention in recent times.</p><p><strong>Objective: </strong>This review aimed to evaluate the immediate (up to 24 hours), intermediate (up to 6 weeks), and long term (6-10 weeks) effects of BFRT plus exercises (EX) compared to EX only on athletic performance (sprint and jump performance), muscle strength, and hypertrophy in athletes and physically active population.</p><p><strong>Methods: </strong>A literature search was conducted to select randomized controlled trials across four electronic databases from inception till April 2021. The search yielded twenty-seven studies in total.</p><p><strong>Results: </strong>Based on eligibility criteria, twenty-one studies were analyzed. No differences were found between both groups for immediate (standardized mean difference [SMD] -0.02, 95% confidence interval [CI] -0.31, 0.27) and long-term effects (SMD -0.30, 95%CI -0.90, 0.30) on sprint performance. For jump performance, no significant effect was observed immediately (SMD -0.02 (95% CI -1.06, 1.02) and long term (SMD -0.40 (95% CI -1.46, 0.67). Similarly, muscle torque at intermediate (SMD 0.90 (95% CI -1.01, 2.81) and long term (SMD -0.54 (95% CI -1.19, 0.12), muscle strength at intermediate (SMD 1.12 (95% CI 0.20, 2.04), and long term (SMD -0.07 (95% CI -0.56, 0.42) also showed non-significant effects. Muscle hypertrophy at intermediate (SMD 0.16 (95% CI -0.31, 0.63) and long term (SMD -0.20 (95% CI -0.90, 0.50) were not statistically significant.</p><p><strong>Conclusions: </strong>There was no significant difference observed in BFRT plus EX group compared to the EX-group on athletic performance, muscle strength, and muscle hypertrophy.</p>\",\"PeriodicalId\":49498,\"journal\":{\"name\":\"Somatosensory and Motor Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Somatosensory and Motor Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/08990220.2023.2181328\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/2/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Somatosensory and Motor Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08990220.2023.2181328","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
摘要
背景：血流限制疗法（BFRT）的益处近来备受关注：本综述旨在评估血流限制疗法加运动（EX）与仅加运动（EX）相比，对运动员和体力活动人口的运动表现（冲刺和跳跃表现）、肌肉力量和肥大的即时（最多 24 小时）、中期（最多 6 周）和长期（6-10 周）影响：方法：通过文献检索，在四个电子数据库中选择了从开始到 2021 年 4 月的随机对照试验。结果：根据资格标准，共有 21 项研究被选中：根据资格标准，对 21 项研究进行了分析。两组研究对短跑成绩的即时影响（标准化平均差 [SMD] -0.02，95% 置信区间 [CI] -0.31，0.27）和长期影响（SMD -0.30，95%CI -0.90，0.30）均未发现差异。对于跳跃成绩，没有观察到明显的即时影响（SMD -0.02 (95%CI -1.06, 1.02)）和长期影响（SMD -0.40 (95%CI -1.46, 0.67)）。同样，中期（SMD 0.90 (95% CI -1.01, 2.81)）和长期（SMD -0.54 (95% CI -1.19, 0.12)）的肌肉扭矩、中期（SMD 1.12 (95% CI 0.20, 2.04)）和长期（SMD -0.07 (95% CI -0.56, 0.42)）的肌肉力量也显示出非显著影响。中期（SMD 0.16 (95% CI -0.31, 0.63)）和长期（SMD -0.20 (95% CI -0.90, 0.50)）的肌肉肥大在统计学上并不显著：结论：BFRT 加 EX 组与 EX 组相比，在运动表现、肌肉力量和肌肉肥大方面没有明显差异。
Blood flow restriction therapy with exercise are no better than exercise alone in improving athletic performance, muscle strength, and hypertrophy: a systematic review and meta-analysis.
Background: The benefits of Blood Flow Restriction Therapy (BFRT) have gained attention in recent times.
Objective: This review aimed to evaluate the immediate (up to 24 hours), intermediate (up to 6 weeks), and long term (6-10 weeks) effects of BFRT plus exercises (EX) compared to EX only on athletic performance (sprint and jump performance), muscle strength, and hypertrophy in athletes and physically active population.
Methods: A literature search was conducted to select randomized controlled trials across four electronic databases from inception till April 2021. The search yielded twenty-seven studies in total.
Results: Based on eligibility criteria, twenty-one studies were analyzed. No differences were found between both groups for immediate (standardized mean difference [SMD] -0.02, 95% confidence interval [CI] -0.31, 0.27) and long-term effects (SMD -0.30, 95%CI -0.90, 0.30) on sprint performance. For jump performance, no significant effect was observed immediately (SMD -0.02 (95% CI -1.06, 1.02) and long term (SMD -0.40 (95% CI -1.46, 0.67). Similarly, muscle torque at intermediate (SMD 0.90 (95% CI -1.01, 2.81) and long term (SMD -0.54 (95% CI -1.19, 0.12), muscle strength at intermediate (SMD 1.12 (95% CI 0.20, 2.04), and long term (SMD -0.07 (95% CI -0.56, 0.42) also showed non-significant effects. Muscle hypertrophy at intermediate (SMD 0.16 (95% CI -0.31, 0.63) and long term (SMD -0.20 (95% CI -0.90, 0.50) were not statistically significant.
Conclusions: There was no significant difference observed in BFRT plus EX group compared to the EX-group on athletic performance, muscle strength, and muscle hypertrophy.
期刊介绍：
Somatosensory & Motor Research publishes original, high-quality papers that encompass the entire range of investigations related to the neural bases for somatic sensation, somatic motor function, somatic motor integration, and modeling thereof. Comprising anatomical, physiological, biochemical, pharmacological, behavioural, and psychophysical studies, Somatosensory & Motor Research covers all facets of the peripheral and central processes underlying cutaneous sensation, and includes studies relating to afferent and efferent mechanisms of deep structures (e.g., viscera, muscle). Studies of motor systems at all levels of the neuraxis are covered, but reports restricted to non-neural aspects of muscle generally would belong in other journals.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
